HomeANAB • NASDAQ
add
AnaptysBio Inc
Previous close
$43.30
Day range
$43.60 - $44.84
Year range
$12.21 - $45.32
Market cap
1.23B USD
Avg Volume
632.52K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 76.32M | 154.26% |
Operating expense | 10.21M | -3.34% |
Net income | 15.11M | 146.00% |
Net profit margin | 19.80 | 118.09% |
Earnings per share | 0.52 | 145.61% |
EBITDA | 34.84M | 254.09% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 248.96M | -42.12% |
Total assets | 353.10M | -28.44% |
Total liabilities | 382.51M | -6.49% |
Total equity | -29.42M | — |
Shares outstanding | 27.69M | — |
Price to book | -40.47 | — |
Return on assets | 25.21% | — |
Return on capital | 28.04% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 15.11M | 146.00% |
Cash from operations | -27.36M | -171.12% |
Cash from investing | 103.28M | 76.19% |
Cash from financing | -10.39M | -114.59% |
Net change in cash | 65.54M | -45.28% |
Free cash flow | -35.59M | -159.73% |
About
Founded
2005
Headquarters
Website
Employees
136
